Literature DB >> 17972950

Efficient gene transfer in CLL by mRNA electroporation.

F Van Bockstaele1, V Pede, E Naessens, S Van Coppernolle, V Van Tendeloo, B Verhasselt, J Philippé.   

Abstract

Chronic lymphocytic leukemia (CLL) consists of at least two major prognostic subgroups, characterized by different cellular and molecular markers. This observation sparked studies on the function and clinical importance of these markers. In order to address their function adequately, an efficient and reliable method for gene transfer is needed. In this study, we compared efficiency and utility of different gene transfer techniques in CLL. Lenti-, retro- and adenoviral transduction did not yield appreciable numbers of marker gene enhanced green fluorescent protein (EGFP) positive CLL cells, despite various prestimulation protocols. Efficient transgene expression was observed after nucleofection of CLL cells with plasmid DNA, at the expense of low survival rates. After optimization, electroporation of in vitro transcribed mRNA yielded up to 90% EGFP+CLL cells without affecting survival. Transgene expression remained detectable for at least 2 weeks after electroporation. Furthermore, we could demonstrate overexpression of ZAP70 and of a ZAP70-EGFP fusion protein after electroporation with ZAP70 or ZAP70-EGFP mRNA. We conclude that mRNA electroporation is a novel and straightforward method for highly efficient gene transfer in CLL. The application of this technique should facilitate functional studies on CLL cells, as well as clinical research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17972950     DOI: 10.1038/sj.leu.2405007

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  12 in total

Review 1.  Physical methods of nucleic acid transfer: general concepts and applications.

Authors:  Julien Villemejane; Lluis M Mir
Journal:  Br J Pharmacol       Date:  2009-01-21       Impact factor: 8.739

2.  Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.

Authors:  Laurence Pearce; Liam Morgan; Thet Thet Lin; Saman Hewamana; R James Matthews; Silvia Deaglio; Clare Rowntree; Christopher Fegan; Christopher Pepper; Paul Brennan
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

3.  Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.

Authors:  Deepa Sampath; Chaomei Liu; Karthik Vasan; Melanie Sulda; Vinay K Puduvalli; William G Wierda; Michael J Keating
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

4.  Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.

Authors:  Mehran Gholamin; Omeed Moaven; Moein Farshchian; Mahmoud Mahmoudi; Mojtaba Sankian; Bahram Memar; Mohammad Naser Forghani; Reza Malekzadeh; Mohammad Taghi Rajabi-Mashhadi; Mohammad Reza Abbaszadegan
Journal:  BMC Cancer       Date:  2010-06-07       Impact factor: 4.430

5.  Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.

Authors:  Deepa Sampath; George A Calin; Vinay K Puduvalli; Gopal Gopisetty; Cristian Taccioli; Chang-Gong Liu; Brett Ewald; Chaomei Liu; Michael J Keating; William Plunkett
Journal:  Blood       Date:  2008-12-18       Impact factor: 22.113

6.  Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia.

Authors:  V El-Khoury; S Pierson; E Szwarcbart; N H C Brons; O Roland; S Cherrier-De Wilde; L Plawny; E Van Dyck; G Berchem
Journal:  Leukemia       Date:  2014-01-14       Impact factor: 11.528

7.  Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation.

Authors:  Ans Rombout; Sofie Lust; Fritz Offner; Evelien Naessens; Bruno Verhasselt; Jan Philippé
Journal:  Br J Cancer       Date:  2016-02-25       Impact factor: 7.640

8.  Nanochannel Electroporation as a Platform for Living Cell Interrogation in Acute Myeloid Leukemia.

Authors:  Xi Zhao; Xiaomeng Huang; Xinmei Wang; Yun Wu; Ann-Kathrin Eisfeld; Sebastian Schwind; Daniel Gallego-Perez; Pouyan E Boukany; Guido I Marcucci; Ly James Lee
Journal:  Adv Sci (Weinh)       Date:  2015-07-16       Impact factor: 16.806

Review 9.  Electrical Stimulation for Immune Modulation in Cancer Treatments.

Authors:  Ritopa Das; Sofia Langou; Thinh T Le; Pooja Prasad; Feng Lin; Thanh D Nguyen
Journal:  Front Bioeng Biotechnol       Date:  2022-01-11

10.  CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression.

Authors:  Valerie Pede; Ans Rombout; Jolien Vermeire; Evelien Naessens; Pieter Mestdagh; Nore Robberecht; Hanne Vanderstraeten; Nadine Van Roy; Jo Vandesompele; Frank Speleman; Jan Philippé; Bruno Verhasselt
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.